| scholarly article | Q13442814 |
| P2093 | author name string | Yannick Cerantola | |
| Maurice Anidjar | |||
| Franck Bladou | |||
| Vincent Pelsser | |||
| Eléonore Haberer | |||
| Simon Gauvin | |||
| Stephan Probst | |||
| P2860 | cites work | The Utility of Molecular Imaging in Prostate Cancer | Q26764746 |
| Histological outcomes after focal high-intensity focused ultrasound and cryotherapy | Q26820469 | ||
| Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers | Q28217662 | ||
| The role of focal therapy in the management of localised prostate cancer: a systematic review | Q34266167 | ||
| Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience | Q34394882 | ||
| The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer | Q35043569 | ||
| Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy | Q36458146 | ||
| [(18)F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results | Q36489655 | ||
| Imaging of prostate cancer local recurrences: why and how? | Q37634367 | ||
| A systematic review of the role of imaging before salvage radiotherapy for post-prostatectomy biochemical recurrence | Q37641490 | ||
| 18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients | Q37696901 | ||
| The role of 11C-choline and 18F-fluorocholine positron emission tomography (PET) and PET/CT in prostate cancer: a systematic review and meta-analysis | Q38102842 | ||
| EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. | Q38160994 | ||
| EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. | Q38169849 | ||
| ¹⁸F-choline positron emission tomography/computed tomography-driven high-dose salvage radiation therapy in patients with biochemical progression after radical prostatectomy: feasibility study in 60 patients | Q38236058 | ||
| Metastasis-directed therapy of regional and distant recurrences after curative treatment of prostate cancer: a systematic review of the literature | Q38252871 | ||
| Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure? | Q38260563 | ||
| Imaging of prostate cancer with PET/CT using (18)F-Fluorocholine | Q38479113 | ||
| Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional Analysis. | Q38983173 | ||
| 68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CT | Q39922053 | ||
| Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate canc | Q41482900 | ||
| Gleason score at diagnosis predicts the rate of detection of 18F-choline PET/CT performed when biochemical evidence indicates recurrence of prostate cancer: experience with 1,000 patients | Q41634353 | ||
| Clinical utility of (18)F-fluorocholine positron-emission tomography/computed tomography (PET/CT) in biochemical relapse of prostate cancer after radical treatment: results of a multicentre study | Q45346212 | ||
| Limited value of bone scintigraphy and computed tomography in assessing biochemical failure after radical prostatectomy | Q46906902 | ||
| A comparison of the single and double factor high-risk models for risk assignment of prostate cancer treated with 3D conformal radiotherapy | Q47600890 | ||
| (18)F-choline PET/CT for early detection of metastases in biochemical recurrence following radical prostatectomy. | Q53018341 | ||
| Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil. | Q53083003 | ||
| Clinical impact of 18F-choline PET/CT in patients with recurrent prostate cancer. | Q53171288 | ||
| [18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients. | Q53527477 | ||
| Is the detection rate of 18F-choline PET/CT influenced by androgen-deprivation therapy? | Q57817247 | ||
| The Long-Term Clinical Impact of Biochemical Recurrence of Prostate Cancer 5 or More Years After Radical Prostatectomy | Q79130735 | ||
| Radionuclide bone scintigraphy in patients with biochemical recurrence after radical prostatectomy: when is it indicated? | Q80412911 | ||
| Influence of PSA, PSA velocity and PSA doubling time on contrast-enhanced 18F-choline PET/CT detection rate in patients with rising PSA after radical prostatectomy | Q83199552 | ||
| Early localization of recurrent prostate cancer after prostatectomy by endorectal coil magnetic resonance imaging | Q95418208 | ||
| P433 | issue | 1-2 | |
| P304 | page(s) | 47-52 | |
| P577 | publication date | 2017-01-01 | |
| P1433 | published in | Canadian Urological Association journal | Q26842808 |
| P1476 | title | Initial single-centre Canadian experience with 18F-fluoromethylcholine positron emission tomography-computed tomography (18F-FCH PET/CT) for biochemical recurrence in prostate cancer patients initially treated with curative intent | |
| P478 | volume | 11 |
Search more.